Peijia Medical Limited announced that on 25 June, 2021, the Company received the approval from the National Medical Products Administration of the PRC of the registration application for TaurusElite®, the Company's second-generation transcatheter aortic valve replacement device. Like the Group's first-generation TAVR product TaurusOne ®, TaurusElite ® has the bovine prosthetic aortic valve. However, TaurusElite ® goes beyond the design of TaurusOne ®, and contains a delivery catheter system with retrieving function, allowing physicians to retrieve and reposition the PAV if the initial release position is not ideal, thereby further improving the safety of the TAVR procedure.